Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of an Acellular Osteochondral Graft for Cartilage LEsions ("EAGLE") European Post Market Study

NCT02309957 is registered in ClinicalTrials.gov with Kensey Nash Corporation as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02309957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of an Acellular Osteochondral Graft for Cartilage LEsions ("EAGLE") European Post Market Study
Lead sponsor
Kensey Nash Corporation
Phase
Observational
Overall status
Completed
Start date
May 31, 2011
Completion date
August 31, 2019
Enrollment
33 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute knee cartilage injury, tear of articular cartilage of knee, current